Resveratrol analogue, trans-4, 4′-dihydroxystilbene (DHS), inhibits melanoma tumor growth and suppresses its metastatic colonization in lungs B Saha, GB Pai, M Subramanian, P Gupta, M Tyagi, BS Patro, ... Biomedicine & Pharmacotherapy 107, 1104-1114, 2018 | 31 | 2018 |
Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition G Pai Bellare, B Saha, BS Patro British Journal of Cancer 124 (7), 1260-1274, 2021 | 29 | 2021 |
Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux GP Bellare, BS Patro Biochemical Pharmacology 199, 115024, 2022 | 26 | 2022 |
trans-4, 4’-Dihydroxystilbene (DHS) inhibits human neuroblastoma tumor growth and induces mitochondrial and lysosomal damages in neuroblastoma cell lines B Saha, BS Patro, M Koli, G Pai, J Ray, SK Bandyopadhyay, ... Oncotarget 8 (43), 73905, 2017 | 26 | 2017 |
Study of smart antibacterial PCL‐xFe3O4 thin films using mouse NIH‐3T3 fibroblast cells in vitro G Pai B, AV Kulkarni, S Jain Journal of Biomedical Materials Research Part B: Applied Biomaterials 105 (4 …, 2017 | 10 | 2017 |
Excitation frequency effect on breast cancer cell death by atmospheric pressure cold plasma V Chaturvedi Misra, G Pai B, N Tiwari, BS Patro, S Ghorui Plasma Chemistry and Plasma Processing 43 (2), 467-490, 2023 | 6 | 2023 |
Cross-Talk Between DNA Damage and Autophagy and Its Implication in Cancer Therapy GP Bellare, P Gupta, S Chakraborty, M Tyagi, BS Patro Autophagy in tumor and tumor microenvironment, 61-76, 2020 | 4* | 2020 |
Investigating the characteristics of 11 kHz excitation of EFCAP and its selective effect on breast cancer cell death VC Misra, G Pai Bellare, N Tiwari, BS Patro, S Ghorui Plasma Processes and Polymers 20 (10), e2300081, 2023 | 1 | 2023 |
Combinatorial Anticancer Effects of The Non-Invasive High Voltage micro-second Pulse Electric Field with Low-Dose Curcumin on A549 Cells G KUMAR, G Pai, R Singh, SB Shelar, BS Patro, A Roy, R Sarathi, ... | | 2023 |